Clinical trials
Phase 2 Leukemia, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 9 |
| Recruiting | 6 |
| Active, not recruiting | 6 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| German CLL Study Group | 4 |
| GlaxoSmithKline | 4 |
| Center for International Blood and Marrow Transplant Research | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| French Innovative Leukemia Organisation | 2 |
| Merck Sharp & Dohme LLC | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Brown University | 1 |
| CABYC | 1 |
| Cylene Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 47 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 19 |
| Leukemia | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Lymphoma, Non-Hodgkin | 8 |
| Leukemia, Lymphoid | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, B-Cell | 5 |
| Myelodysplastic Syndromes | 5 |
Trials
Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.